SAN FRANCISCO--(BUSINESS WIRE)--California Life Sciences Association (CLSA) today announced the addition of five new members to its board of directors. Senior executives from Actelion Pharmaceuticals, Alexandria Real Estate Equities, Johnson & Johnson Innovation, JLABS, Leerink Partners and Sanofi Genzyme joined the board, adding to the diverse background and expertise of the directing body.
